Observation series — PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
← FDA process analytical framework
110 observation(s) recorded. 110 carry an address; none is without one. 110 retained normalised text and hold a digest.
Each observation is addressed by this row’s identifier, the date it was observed, and its sequence within that date — the same key /api/v1/series.jsonl publishes as `sequence`, counted in the order the store recorded them.
This digest is a leaf of the integrity root, and the command that recomputes it is published at /verify.
Every addressed record below carries its own citation, naming the day, the URL that answered, the response as recorded, and the digest where one exists. Where none exists the citation says so and asserts no digest.
| Address | Date | Outcome | Method | Normalised text | SHA-256 of normalised text |
|---|---|---|---|---|---|
2026-07-31·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-07-31·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-07-31 (record 1 of that day)
Requested: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 35,262 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-07-31-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,262 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-07-31·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-07-31·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-07-31 (record 2 of that day)
Requested: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 35,262 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-07-31-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,262 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-07-31·3 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-07-31·3
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-07-31 (record 3 of that day)
Requested: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 35,262 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-07-31-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,262 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-07-31·4 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-07-31·4
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-07-31 (record 4 of that day)
Requested: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 35,262 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-07-31-4
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,262 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-07-31·5 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-07-31·5
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-07-31 (record 5 of that day)
Requested: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 35,262 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-07-31-5
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,262 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-07-31·6 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-07-31·6
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-07-31 (record 6 of that day)
Requested: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 35,262 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31 — the day this
observation was recorded, UTC.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-07-31-6
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,262 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-01·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-01·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-01 (record 1 of that day)
Requested: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 35,269 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-01 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-01-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,269 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-01·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-01·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-01 (record 2 of that day)
Requested: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 35,269 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-01 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-01-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,269 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-01·3 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-01·3
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-01 (record 3 of that day)
Requested: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 35,264 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-02 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-01-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,264 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-02·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-02·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-02 (record 1 of that day)
Requested: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 35,264 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-02 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-02-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,264 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-02·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-02·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-02 (record 2 of that day)
Requested: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 35,264 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-02 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-02-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,264 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-02·3 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-02·3
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-02 (record 3 of that day)
Requested: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 35,264 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-02 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-02-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,264 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-03·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-03·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-03 (record 1 of that day)
Requested: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 35,264 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-03 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-03-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,264 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-03·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-03·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-03 (record 2 of that day)
Requested: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(no answering URL was recorded for this observation)
Response: HTTP 200, fetched direct, 35,264 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-03 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-03-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,264 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-03·3 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-03·3
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-03 (record 3 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,264 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-03 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-03-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,264 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-04·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-04·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-04 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,263 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-04 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-04-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,263 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-04·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-04·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-04 (record 2 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,263 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-04 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-04-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,263 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-05·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-05·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-05 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,261 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-05-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,261 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-05·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-05·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-05 (record 2 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,261 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-05-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,261 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-05·3 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-05·3
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-05 (record 3 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,261 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-05-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,261 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-06·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-06·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-06 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,259 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-06 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-06-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,259 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-06·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-06·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-06 (record 2 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,259 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-06 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-06-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,259 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-07·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-07·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-07 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,267 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-07 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-07-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,267 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-08·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-08·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-08 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,260 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-08 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-08-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,260 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-08·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-08·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-08 (record 2 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,260 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-08 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-08-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,260 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-08·3 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-08·3
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-08 (record 3 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,260 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-08 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-08-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,260 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-08·4 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-08·4
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-08 (record 4 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,260 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-08 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-08-4
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,260 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-09·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-09·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-09 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,260 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-09 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-09-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,260 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-09·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-09·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-09 (record 2 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,260 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-09 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-09-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,260 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-09·3 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-09·3
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-09 (record 3 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,260 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-09 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-09-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,260 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-09·4 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-09·4
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-09 (record 4 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,260 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-09 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-09-4
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,260 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-09·5 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-09·5
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-09 (record 5 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,260 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-09 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-09-5
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,260 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-09·6 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-09·6
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-09 (record 6 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,260 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-09 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-09-6
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,260 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-09·7 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-09·7
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-09 (record 7 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,260 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-09 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-09-7
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,260 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-09·8 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-09·8
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-09 (record 8 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,260 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-09 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-09-8
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,260 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-10·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-10·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-10 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,259 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-10 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-10-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,259 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-10·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-10·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-10 (record 2 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,259 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-10 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-10-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,259 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-10·3 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-10·3
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-10 (record 3 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,259 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-10 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-10-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,259 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-10·4 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-10·4
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-10 (record 4 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,259 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-10 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-10-4
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,259 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-10·5 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-10·5
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-10 (record 5 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,259 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-10 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-10-5
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,259 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-10·6 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-10·6
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-10 (record 6 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,271 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-11 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-10-6
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,271 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-11·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-11·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-11 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,271 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-11 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-11-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,271 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-11·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-11·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-11 (record 2 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,254 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-11-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,254 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-11·3 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-11·3
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-11 (record 3 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,254 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-11-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,254 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-12·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-12·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-12 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,254 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-12-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,254 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-12·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-12·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-12 (record 2 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,254 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-12-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,254 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-12·3 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-12·3
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-12 (record 3 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,254 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-12-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,254 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-12·4 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-12·4
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-12 (record 4 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,254 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-12-4
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,254 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-12·5 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-12·5
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-12 (record 5 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,254 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-12-5
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,254 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-12·6 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-12·6
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-12 (record 6 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,254 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-12-6
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,254 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-12·7 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-12·7
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-12 (record 7 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,254 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-12-7
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,254 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-12·8 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-12·8
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-12 (record 8 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,254 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-12-8
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,254 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-12·9 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-12·9
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-12 (record 9 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,254 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-12-9
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,254 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-13·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-13·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-13 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,265 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-13 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-13-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,265 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-14·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-14·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-14 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,258 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-14 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-14-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,258 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-15·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-15·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-15 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,267 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-15 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-15-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,267 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-15·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-15·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-15 (record 2 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,267 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-15 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-15-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,267 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-15·3 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-15·3
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-15 (record 3 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,267 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-15 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-15-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,267 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-16·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-16·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-16 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,261 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-16 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-16-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,261 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-16·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-16·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-16 (record 2 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,261 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-16 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-16-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,261 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-16·3 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-16·3
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-16 (record 3 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,261 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-16 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-16-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,261 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-16·4 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-16·4
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-16 (record 4 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,261 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-16 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-16-4
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,261 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-17·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-17·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-17 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,264 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-17 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-17-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,264 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-18·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-18·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-18 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,262 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-18 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-18-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,262 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-19·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-19·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-19 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,270 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-19 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-19-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,270 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-20·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-20·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-20 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,265 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-20 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-20-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,265 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-21·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-21·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-21 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,267 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-21 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-21-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,267 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-22·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-22·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-22 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,256 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-22 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-22-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,256 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-22·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-22·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-22 (record 2 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,256 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-22 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-22-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,256 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-23·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-23·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-23 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,266 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-23 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-23-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,266 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-24·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-24·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-24 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,261 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-24 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-24-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,261 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-25·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-25·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-25 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,262 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-25 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-25-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,262 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-25·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-25·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-25 (record 2 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,262 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-25 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-25-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,262 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-26·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-26·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-26 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,253 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-26 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-26-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,253 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-26·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-26·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-26 (record 2 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,253 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-26 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-26-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,253 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-27·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-27·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-27 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,265 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-27 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-27-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,265 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-28·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-28·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-28 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,265 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-28 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-28-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,265 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-29·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-29·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-29 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,260 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-29 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-29-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,260 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-29·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-29·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-29 (record 2 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,260 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-29 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-29-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,260 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-30·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-30·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-30 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,255 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-30 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-30-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,255 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-30·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-30·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-30 (record 2 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,255 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-30 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-30-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,255 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-08-31·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-08-31·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-08-31 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,270 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-08-31 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-08-31-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,270 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-01·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-01·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-01 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,254 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-01 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-01-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,254 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-02·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-02·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-02 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 35,260 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-02 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-02-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 35,260 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-02·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-02·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-02 (record 2 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,755 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-02 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-02-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,755 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-03·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-03·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-03 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,745 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-03 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-03-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,745 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-04·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-04·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-04 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,759 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-04 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-04-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,759 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-04·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-04·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-04 (record 2 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,759 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-04 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-04-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,759 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-05·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-05·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-05 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,750 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-05-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,750 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-05·2 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-05·2
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-05 (record 2 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,750 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-05-2
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,750 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-05·3 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-05·3
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-05 (record 3 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,750 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-05-3
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,750 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-05·4 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-05·4
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-05 (record 4 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,750 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-05-4
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,750 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-05·5 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-05·5
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-05 (record 5 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,750 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-05-5
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,750 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-05·6 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-05·6
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-05 (record 6 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,750 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-05-6
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,750 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-05·7 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-05·7
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-05 (record 7 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,750 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-05-7
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,750 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-05·8 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-05·8
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-05 (record 8 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,750 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-05-8
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,750 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-05·9 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-05·9
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-05 (record 9 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,750 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-05 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-05-9
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,750 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-06·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-06·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-06 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,755 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-06 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-06-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,755 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-07·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-07·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-07 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,746 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-07 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-07-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,746 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-08·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-08·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-08 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,755 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-08 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-08-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,755 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-09·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-09·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-09 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,749 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-09 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-09-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,749 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-10·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-10·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-10 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,756 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-10 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-10-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,756 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-11·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-11·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-11 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,749 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-11 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-11-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,749 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-12·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-12·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-12 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,751 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-12 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-12-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,751 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-13·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-13·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-13 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,753 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-13 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-13-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,753 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-14·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-14·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-14 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,752 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-14 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-14-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,752 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-15·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-15·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-15 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,789 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-15 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-15-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,789 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-16·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-16·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-16 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,756 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-16 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-16-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,756 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-17·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-17·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-17 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,905 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-17 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-17-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,905 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 | |
2026-09-18·1 Cite this observationGxPlex observation record fda-process-analytical-framework 2026-09-18·1
Document: PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance
Observed: 2026-09-18 (record 1 of that day)
Answered at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
Response: HTTP 200, fetched direct, 34,912 bytes returned
Digest: SHA-256 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583
1,419 characters of normalised text.
The digest is of the NORMALISED text, not of the bytes served:
tags, scripts, navigation and volatile strings are removed before
hashing, so hashing the source as served will not reproduce it.
Normalisation is described at https://gxplex.com/methodology; the
command that recomputes a digest is published at
https://gxplex.com/verify.
Capture: https://web.archive.org/web/20260731221422/https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pat-framework-innovative-pharmaceutical-development-manufacturing-and-quality-assurance
(Internet Archive, submitted 2026-07-31, before this observation
was recorded on 2026-09-18 UTC. NOT a capture of this
observation.)
Permalink: https://gxplex.com/observations/fda-process-analytical-framework#obs-2026-09-18-1
Full record: https://gxplex.com/api/v1/series.jsonl | HTTP 200 · 34,912 bytes returned | direct | 1,419 chars | 2104fa7291118f7b2c32febab83febdb592ccdc57470da9fe276ffb6cf1fc583 |
Every record above is published untruncated at /api/v1/series.jsonl,
which carries the same sequence these addresses are built
from.